Diagnosis of erectile dysfunction

  • A. Abdel RaheemEmail author
  • C. -Y. Li
  • G. Garaffa
  • A. Sacca
  • D. J. Ralph
Review Article


Erectile dysfunction (ED) is a problem that may affect up to 52% of men aged between 40 and 70. In the era of type-5 phosphodiesterase (PDE5) inhibitors, the treatment of ED can be simple and effective after the correct diagnosis which is made in the majority of cases with history, examination and some basic laboratory tests.


Erectile dysfunction diagnosis review 


  1. 1.
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993; Jul 7;270(1):83–90.CrossRefGoogle Scholar
  2. 2.
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J.Urol. 1994; Jan;151(1):54–61.PubMedGoogle Scholar
  3. 3.
    Wagner G, Fugl Meyer KS, Fugl Meyer AR. Impact of erectile dysfunction on quality of life: Patient and partner perspectives. Int.J.Impot.Res. 2000; Oct;12Suppl 4:S144–146.PubMedCrossRefGoogle Scholar
  4. 4.
    Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur. Urol. 2005; Sep;48(3):512,8; discussion 517–8.PubMedGoogle Scholar
  5. 5.
    Rosen RC, Hatzichristou D, Broderick G, Clayton A, Cuzin B, Derogatis L et al. Clinical evaluation and symptom scales: Sexual dysfunction assessment in men. In: Lue TF, Bosson R, Rosen RC, Guiliano F, Khoury S, Montorsi F, editors. Sexual medicine: Sexual dysfunction in men and women. 2nd ed. Paris: Health Publications; 2004; 7. p. 173–206.Google Scholar
  6. 6.
    Lue TF. A patient’s goal-directed approach to erectile dysfunction and Peyronie’s disease. Can.J.Urol. 1995;2(Suppl 1):13–17.PubMedGoogle Scholar
  7. 7.
    Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. Chapter 1: The management of erectile dysfunction: An AUA update. J.Urol. 2005; Jul;174(1):230–239.PubMedCrossRefGoogle Scholar
  8. 8.
    Hatzimouratidis K, Hatzichristou DG. A comparative review of the options for treatment of erectile dysfunction: Which treatment for which patient? Drugs. 2005;65(12):1621–1650.PubMedCrossRefGoogle Scholar
  9. 9.
    Hengeveld MW. Erectile disorder: A psychosexological review. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer-Verlag; 1991. p. 207–220.Google Scholar
  10. 10.
    Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur.Urol. 2003; Dec;44(6):637–649.PubMedCrossRefGoogle Scholar
  11. 11.
    Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men’s attitudes to life events and sexuality (FEMALES) study. J.Sex.Med. 2005; Sep;2(5):675–684.PubMedCrossRefGoogle Scholar
  12. 12.
    Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: The COBRA trial. Eur.Heart J. 2006; Nov;27(22):2632–2639.PubMedCrossRefGoogle Scholar
  13. 13.
    Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J.Urol. 2004; Jun;171(6 Pt 1):2341–2345.PubMedCrossRefGoogle Scholar
  14. 14.
    Chiurlia E, D’Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J.Am.Coll.Cardiol. 2005; Oct 18;46(8):1503–1506.PubMedCrossRefGoogle Scholar
  15. 15.
    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int.J.Impot.Res. 1999; Dec;11(6):319–326.PubMedCrossRefGoogle Scholar
  16. 16.
    Sheehan TJ, Fifield J, Reisine S, Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J.Pers.Assess. 1995; Jun;64(3):507–521.PubMedCrossRefGoogle Scholar
  17. 17.
    Esposito K, Giugliano D. Obesity, the metabolic syndrome and sexual dysfunction. Int.J.Impot.Res. 2005; Sep–Oct;17(5):391–398.PubMedCrossRefGoogle Scholar
  18. 18.
    Bouloux PMG, Wass JAH. Endocrinology. In: Kirby RS, Carson CC, Webster GD, editors. Impotence: Diagnosis and management of male erectile dysfunction. 1st ed.: Oxford: Butterworth-Heinemann; 1991. p. 44–54.Google Scholar
  19. 19.
    Bondil P, Louis JF, Daures JP, Costa P, Navratil H. Extensibilité pénienne et fonction érectile. Résultats préliminaires. [Penile extensibility and erectile function. Preliminary results]. Ann.Urol.(Paris). 1990;24(5):373–377.Google Scholar
  20. 20.
    Lewis RW, King BF. The diagnostic algorithm. In: Bennett AH, editor. Impotence: Diagnosis and management of erectile dysfunction. Philadelphia: W.B. Saunders Company; 1994. p. 42–51.Google Scholar
  21. 21.
    Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur.Urol. 2003; Sep;44(3):360,4; discussion 364–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Mikhail N. Does testosterone have a role in erectile function? Am.J.Med. 2006; May;119(5):373–382.PubMedCrossRefGoogle Scholar
  23. 23.
    Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J.Clin.Endocrinol. Metab. 2003; Jun;88(6):2673–2681.PubMedCrossRefGoogle Scholar
  24. 24.
    Cilurzo P, Canale D, Turchi P, Giorgi PM, Menchini Fabris GF. Il Rigiscan system nella diagnostica dell’impotenza sessuale maschile. [The Rigiscan system in the diagnosis of male sexual impotence]. Arch.Ital. Urol.Nefrol.Androl. 1992; Jun;64Suppl 2:81–85.PubMedGoogle Scholar
  25. 25.
    Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study. Urology. 2000; Dec 20;56(6):906–911.PubMedCrossRefGoogle Scholar
  26. 26.
    Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J.Sex.Med. 2007; Sep;4(5):1437–1447.PubMedCrossRefGoogle Scholar
  27. 27.
    Porst H, Derouet H, Idzikowski M et al. Oral phentolamine in erectile dysfunction. Results of a German multicentre study. J.Int.Impot.Res. 1996;8(3):117–132.Google Scholar
  28. 28.
    Seyam R, Mohamed K, Akhras AA, Rashwan H. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1. Int.J. Impot.Res. 2005; Jul–Aug;17(4):346–353.PubMedCrossRefGoogle Scholar
  29. 29.
    Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, et al. Intracavernosal forskolin: Role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J.Urol. 1997; Nov;158(5):1752,8; discussion 1758–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Connolly JA, Borirakchanyavat S, Lue TF. Ultrasound evaluation of the penis for assessment of impotence. J.Clin.Ultrasound. 1996; Oct;24(8):481–486.PubMedCrossRefGoogle Scholar
  31. 31.
    Altinkilic B, Hauck EW, Weidner W. Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction. World J.Urol. 2004; Nov;22(5):361–364.PubMedCrossRefGoogle Scholar
  32. 32.
    Chang JJ, Lue TF. Venous impotence. In: Mulcahy JJ, editor. Topics in clinical urology: Diagnosis and management of male sexual dysfunction. New York: Igaku-Shoin Medical Publishers, Inc.; 1997. p. 148–163.Google Scholar
  33. 33.
    McDougal WS, Jeffery RF. Microscopic penile revascularization. J.Urol. 1983; Mar;129(3):517–521.PubMedGoogle Scholar
  34. 34.
    Ciampalini S, Savoca G, Buttazzi L, Gattuccio I, Mucelli FP, Bertolotto M, et al. High-flow priapism: Treatment and long-term follow-up. Urology. 2002; Jan;59(1):110–113.PubMedCrossRefGoogle Scholar
  35. 35.
    Goldstein I. Evaluation of penile nerves. In: Tanagho EA, Lue TF, McClure RD, editors. Contemporary management of impotence and infertility. Baltimore: Williams and Wilkins; 1988. p. 71.Google Scholar
  36. 36.
    Lue TF, Broderick G. Evaluation and non-surgical management of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED, editors. Campbell’s urology. Philadelphia: WB Saunders; 1998. p. 1181–213.Google Scholar
  37. 37.
    Bemelmans BLH, Meuleman EJH, Anten BMW et al. Penile sensory disorders in erectile dysfunction. Results of a comprehensive neuro-uro-physiological diagnostic workup in 123 patients. In: Meuleman EJH, editor. Recent progress in the diagnosis of erectile dysfunction. Nijemegen: Benda; 1991. p. 81–94.Google Scholar
  38. 38.
    Daffertshofer M, Linden D, Syren M, Junemann KP, Berlit P. Assessment of local sympathetic function in patients with erectile dysfunction. Int.J.Impot.Res. 1994; Dec;6(4):213–225.PubMedGoogle Scholar
  39. 39.
    Jost WH, Derouet H, Osterhage J, Schimrigk K, Ziegler M. Elektrophysiologische Diagnostik bei der erektilen Dysfunktion. [Electrophysiologic diagnosis in erectile dysfunction]. Urologe A. 1996; Mar;35(2):120–126.PubMedGoogle Scholar

Copyright information

© PAUSA and Springer Verlag France 2009

Authors and Affiliations

  • A. Abdel Raheem
    • 1
    Email author
  • C. -Y. Li
    • 1
  • G. Garaffa
    • 1
  • A. Sacca
    • 1
  • D. J. Ralph
    • 1
  1. 1.St. Peter’s Department of AndrologyThe Institute of UrologyLondonUK

Personalised recommendations